Safety monitoring for GLP-1 therapy itself includes: Assessment for gastrointestinal adverse effects, which are common but usually transient Monitoring for signs of pancreatitis (severe, persistent abdominal pain) Vigilance for symptoms suggesting thyroid masses (neck lump, difficulty swallowing, persistent hoarseness) Regular review of glycaemic control in diabetic patients Blood pressure and cardiovascular risk factor assessment Monitoring for gallbladder disease (right upper abdominal pain, fever, jaundice) Eye examinations for people with diabetes, particularly those with pre-existing diabetic retinopathy Renal function checks, especially if experiencing severe gastrointestinal symptoms that could lead to dehydration If you have diabetes and take insulin or sulfonylureas, your doctor may reduce these doses when starting GLP-1 therapy to prevent hypoglycaemia
Cardiologists, oncologists, nurse navigators and other specialists communicate directly to align care and support both cancer outcomes and heart health
Unexpected Fatigue: Reasons and Solutions As you delve into your weight loss journey with compounded semaglutide, recognizing the reasons behind your fatigue can help you manage it better
What is fluconazole used for
Concluding remarks The complex interconnection between ROS levels and cancer is essentially based on accurate fine-tuning between ROS production and scavenging
Consult your doctor for personalized advice, especially if pregnant or with other conditions
